LncRNA-disease association prediction method based on heterogeneous information completion and convolutional neural network
This work addresses the challenge of identifying new LDAs for disease warning and treatment, representing an incremental improvement over existing methods in bioinformatics.
The paper tackles the problem of predicting lncRNA-disease associations (LDAs) by proposing HCNNLDA, a deep learning model that combines a heterogeneous network with a convolutional neural network, achieving high performance with an AUC of 0.9752 and AUPR of 0.9740 under 5-fold cross-validation.
The emerging research shows that lncRNA has crucial research value in a series of complex human diseases. Therefore, the accurate identification of lncRNA-disease associations (LDAs) is very important for the warning and treatment of diseases. However, most of the existing methods have limitations in identifying nonlinear LDAs, and it remains a huge challenge to predict new LDAs. In this paper, a deep learning model based on a heterogeneous network and convolutional neural network (CNN) is proposed for lncRNA-disease association prediction, named HCNNLDA. The heterogeneous network containing the lncRNA, disease, and miRNA nodes, is constructed firstly. The embedding matrix of a lncRNA-disease node pair is constructed according to various biological premises about lncRNAs, diseases, and miRNAs. Then, the low-dimensional feature representation is fully learned by the convolutional neural network. In the end, the XGBoot classifier model is trained to predict the potential LDAs. HCNNLDA obtains a high AUC value of 0.9752 and AUPR of 0.9740 under the 5-fold cross-validation. The experimental results show that the proposed model has better performance than that of several latest prediction models. Meanwhile, the effectiveness of HCNNLDA in identifying novel LDAs is further demonstrated by case studies of three diseases. To sum up, HCNNLDA is a feasible calculation model to predict LDAs.